Strategic collaboration between Biotage and Yingsheng in China

Biotage AB has announced a strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd. Yingsheng is mainly focused on independently researching, producing and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry detection platform around metabolomics and genetics. Biotage and Yingsheng have now agreed to develop clinical mass spectrometry applications in China. Biotage will provide systems and consumables within its analytical chemistry portfolio to be sold by Yingsheng under its own brand and together with Yingsheng’s other products and technical solutions.